Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fucicort Lipid Cream in Infected Atopic Dermatitis
NCT03395132Phase 3Terminated
- Sponsor
- LEO Pharma
- Start
- Jul 2018
- Primary completion
- May 2019
- Modality
- Irreversible Covalent Inhibitors, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of fusidic acid, betamethasone dipropionate spray 0.05% in atopic dermatitis (AD), sponsored by LEO Pharma. Started Jul 2018; status: terminated.
02
Drugs
fusidic acidbetamethasone dipropionate spray 0.05%
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NCT03395132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03395132.